VIB Vermögen AG

Informe Stock XTRA:VIH1

Capitalización de mercado: €371.5m

Salud financiera de hoja de balance de VIB Vermögen

Salud financiera controles de criterios 3/6

VIB Vermögen tiene unos fondos propios totales de €809.0M y una deuda total de €907.1M, lo que sitúa su ratio deuda/fondos propios en 112.1%. Sus activos y pasivos totales son €1.8B y €987.0M respectivamente. VIB Vermögen El EBIT de la empresa es de €60.7M, por lo que su ratio de cobertura de intereses es de 4.8. Su tesorería e inversiones a corto plazo ascienden a €365.9M.

Información clave

112.1%

Ratio deuda-patrimonio

€907.08m

Deuda

Ratio de cobertura de intereses4.8x
Efectivo€365.88m
Patrimonio€809.04m
Total pasivo€986.95m
Activos totales€1.80b

Actualizaciones recientes sobre salud financiera

Recent updates

When Should You Buy VIB Vermögen AG (ETR:VIH1)?

Dec 20
When Should You Buy VIB Vermögen AG (ETR:VIH1)?

Is VIB Vermögen (ETR:VIH1) Using Too Much Debt?

Jun 21
Is VIB Vermögen (ETR:VIH1) Using Too Much Debt?

Is Now The Time To Look At Buying VIB Vermögen AG (ETR:VIH1)?

May 30
Is Now The Time To Look At Buying VIB Vermögen AG (ETR:VIH1)?

VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

Mar 29
VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18
VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Feb 11
Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Sep 06
Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Is VIB Vermögen (ETR:VIH1) A Risky Investment?

Oct 15
Is VIB Vermögen (ETR:VIH1) A Risky Investment?

VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment

Mar 11
VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Feb 18
A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend

Jan 19
You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend

Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like

Dec 25
Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like

Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return

Dec 06
Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Nov 18
A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Análisis de la situación financiera

Pasivos a corto plazo: VIH1Los activos a corto plazo (€646.5M) de la empresa superan a sus pasivos a corto plazo (€55.5M).

Pasivo a largo plazo: Los activos a corto plazo de VIH1 (€646.5M) no cubren sus pasivos a largo plazo (€931.5M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de VIH1 (66.9%) se considera alta.

Reducción de la deuda: VIH1 ha pasado de 125.8% a 112.1% en los últimos 5 años.

Cobertura de la deuda: VIH1's debt is not well covered by operating cash flow (7.8%).

Cobertura de intereses: VIH1Los pagos de intereses de su deuda están bien cubiertos por el EBIT (4.8x cobertura).


Hoja de balance


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target